247 related articles for article (PubMed ID: 17112858)
1. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
2. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
[TBL] [Abstract][Full Text] [Related]
4. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3434-6. PubMed ID: 17175295
[TBL] [Abstract][Full Text] [Related]
5. Anemia in heart and kidney allograft recipients: is there a role for hepcidin?
Przybylowski P; Malyszko J; Malyszko JS; Koc-Zorawska E; Sadowski J; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):4255-8. PubMed ID: 21168677
[TBL] [Abstract][Full Text] [Related]
6. A possible role of hepcidin in the pathogenesis of anemia in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1803-7. PubMed ID: 20620527
[TBL] [Abstract][Full Text] [Related]
7. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Wolczynski S; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3466-9. PubMed ID: 19100414
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
9. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
[TBL] [Abstract][Full Text] [Related]
10. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
12. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
[TBL] [Abstract][Full Text] [Related]
13. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand is a marker of kidney function and inflammation in heart and kidney transplant recipients.
Malyszko J; Przybylowski P; Malyszko J; Koc-Zorawska E; Mysliwiec M
Transplant Proc; 2011 Jun; 43(5):1877-80. PubMed ID: 21693293
[TBL] [Abstract][Full Text] [Related]
16. Hemojuvelin and iron metabolism in kidney and heart allograft recipients.
Przybylowski P; Koc-Zorawska E; Glowinska I; Levin-Iaina N; Macdougall IC; Malyszko JS; Mysliwiec M; Malyszko J
Transplant Proc; 2013; 45(1):391-3. PubMed ID: 23375327
[TBL] [Abstract][Full Text] [Related]
17. Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3509-13. PubMed ID: 17175317
[TBL] [Abstract][Full Text] [Related]
18. Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients.
Małyszko J; Małyszko JS; Brzosko S; Wołczynski S; Myśliwiec M
Am J Nephrol; 2005; 25(3):203-10. PubMed ID: 15897668
[TBL] [Abstract][Full Text] [Related]
19. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.
Abdel-Khalek MA; El-Barbary AM; Essa SA; Ghobashi AS
J Rheumatol; 2011 Oct; 38(10):2153-9. PubMed ID: 21885483
[TBL] [Abstract][Full Text] [Related]
20. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.
Aeberli I; Hurrell RF; Zimmermann MB
Int J Obes (Lond); 2009 Oct; 33(10):1111-7. PubMed ID: 19636315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]